1497PJNJ-61186372 (JNJ-372), an EGFR-cMET bispecific antibody, in advanced non-small cell lung cancer (NSCLC): An update on phase I results. (23rd October 2018) - Cho, B C; Lee, J-S; Han, J-Y; Cho, E K; Haura, E; Lee, K H; Bauml, J; Sanborn, R E; Curtis, M; Attiyeh, E; Haddish-Berhane, N; Bae, K; et al.